Quarry LP Grows Stock Position in AngioDynamics, Inc. (NASDAQ:ANGO)

Quarry LP raised its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO) by 75.1% in the second quarter, according to its most recent 13F filing with the SEC. The fund owned 6,047 shares of the medical instruments supplier’s stock after buying an additional 2,594 shares during the period. Quarry LP’s holdings in AngioDynamics were worth $37,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the stock. Systematic Financial Management LP raised its stake in shares of AngioDynamics by 8.4% during the 2nd quarter. Systematic Financial Management LP now owns 2,109,561 shares of the medical instruments supplier’s stock valued at $12,763,000 after buying an additional 162,972 shares during the last quarter. Mackenzie Financial Corp purchased a new position in shares of AngioDynamics in the 2nd quarter valued at about $80,000. Millennium Management LLC increased its stake in shares of AngioDynamics by 41.9% in the 2nd quarter. Millennium Management LLC now owns 1,793,454 shares of the medical instruments supplier’s stock valued at $10,850,000 after purchasing an additional 529,861 shares in the last quarter. Deerfield Management Company L.P. Series C increased its stake in shares of AngioDynamics by 135.1% in the 2nd quarter. Deerfield Management Company L.P. Series C now owns 109,536 shares of the medical instruments supplier’s stock valued at $663,000 after purchasing an additional 62,945 shares in the last quarter. Finally, Cubist Systematic Strategies LLC increased its stake in shares of AngioDynamics by 15.1% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 226,503 shares of the medical instruments supplier’s stock valued at $1,370,000 after purchasing an additional 29,669 shares in the last quarter. Hedge funds and other institutional investors own 89.43% of the company’s stock.

AngioDynamics Stock Down 4.2 %

Shares of AngioDynamics stock opened at $6.10 on Friday. AngioDynamics, Inc. has a twelve month low of $5.26 and a twelve month high of $8.25. The firm has a market cap of $244.34 million, a PE ratio of -1.26 and a beta of 0.65. The business has a 50-day moving average price of $7.48 and a 200 day moving average price of $6.63.

AngioDynamics (NASDAQ:ANGO) last posted its quarterly earnings data on Thursday, October 3rd. The medical instruments supplier reported ($0.11) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.15) by $0.04. AngioDynamics had a negative return on equity of 4.91% and a negative net margin of 61.55%. The company had revenue of $67.50 million for the quarter, compared to analysts’ expectations of $67.93 million. During the same period in the previous year, the firm posted ($0.12) EPS. AngioDynamics’s revenue was down 14.2% compared to the same quarter last year. On average, sell-side analysts expect that AngioDynamics, Inc. will post -0.41 EPS for the current year.

Analysts Set New Price Targets

Several brokerages recently weighed in on ANGO. HC Wainwright restated a “buy” rating and issued a $14.00 price target on shares of AngioDynamics in a research note on Friday. Canaccord Genuity Group cut their price target on AngioDynamics from $13.00 to $12.00 and set a “buy” rating for the company in a research note on Friday.

AngioDynamics Company Profile

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.